Filing Details
- Accession Number:
- 0001478242-17-000079
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-12-22 16:11:08
- Reporting Period:
- 2017-12-20
- Accepted Time:
- 2017-12-22 16:11:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1478242 | Iqvia Holdings Inc. | IQV | Services-Commercial Physical & Biological Research (8731) | 271341991 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1575957 | H James Iii Erlinger | C/O Iqvia Holdings Inc. 4820 Emperor Blvd. Durham NC 27703 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-12-20 | 10,000 | $30.07 | 26,232 | No | 4 | X | Direct | |
| Common Stock | Disposition | 2017-12-20 | 10,000 | $101.21 | 16,232 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | X | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2017-12-20 | 10,000 | $0.00 | 10,000 | $30.07 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 25,000 | 2016-02-07 | 2023-02-07 | No | 4 | X | Direct |
Footnotes
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2017.
- The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $100.86 to $101.66 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
